Appeals Court Affirms that Eon Labs' Itraconazole Does Not Infringe Janssen's Patent
June 13 2005 - 5:41PM
Business Wire
Eon Labs, Inc. (Nasdaq: ELAB) announced today that the United
States Court of Appeals for the Federal Circuit unanimously
affirmed the judgment of the U.S. District Court for the Eastern
District of New York that the Company's generic itraconazole
product does not infringe Janssen Pharmaceutica N.V. and Janssen
Pharmaceutica Products L.P.'s U.S. Patent No. 5,633,015. Eon Labs
is a generic pharmaceutical company specializing in developing,
licensing, manufacturing, selling and distributing a broad range of
prescription pharmaceutical products. For press releases and other
company information, visit the Eon Labs, Inc. website at
www.eonlabs.com. Safe Harbor Statement under the U.S. Private
Securities Litigation Reform Act of 1995: This release contains
statements that are forward-looking in nature which express the
beliefs and expectations of management. Such statements are based
on current plans, estimates and expectations and involve a number
of known and unknown risks, uncertainties and other factors that
could cause the Company's future results, performance or
achievements to differ significantly from the results, performance
or achievements expressed or implied by such forward-looking
statements. These factors and additional information are discussed
in the Company's filings with the Securities and Exchange
Commission and statements in this release should be evaluated in
light of these important factors. Although we believe that these
statements are based upon reasonable assumptions, we cannot
guarantee future results. Forward-looking statements speak only as
of the date on which they are made, and the Company undertakes no
obligation to update publicly or revise any forward-looking
statement, whether as a result of new information, future
developments or otherwise.
Elevai Labs (NASDAQ:ELAB)
Historical Stock Chart
From May 2024 to Jun 2024
Elevai Labs (NASDAQ:ELAB)
Historical Stock Chart
From Jun 2023 to Jun 2024